Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Invesco Solar ETF
TAN
4
Direxion Daily Energy Bull 2X Shares ETF
ERX
5
The Technology Select Sector SPDR® Fund
XLK
US Stock MarketDetailed Quotes
Cardiol Therapeutics (CRDL)
- 1.320
- -0.050-3.65%
Close May 15 16:00 ET
- 1.330
- +0.010+0.76%
Post 19:52 ET
152.16MMarket Cap-4.65P/E (TTM)
1.350High1.290Low473.45KVolume1.340Open1.370Prev Close623.99KTurnover0.47%Turnover RatioLossP/E (Static)115.27MShares1.71052wk High8.63P/B131.85MFloat Cap0.88052wk Low--Dividend TTM99.89MShs Float4.960Historical High--Div Yield TTM4.38%Range %0.450Historical Low1.318Avg Price1Lot Size
CRDL Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
CRDL Orderflow
Unit: --
CRDL Orderflow Trend
IntradayDayWeekMonth
No Data
Cardiol Therapeutics (CRDL) News
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL) and BridgeBio Pharma (BBIO)
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
Cardiol Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Cardiol Therapeutics Inc: INTERIM MDA EN
Cardiol Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
Cardiol Therapeutics (CRDL) Stock Forum
$Western Digital (WDC.US)$
I would recommend $Cardiol Therapeutics (CRDL.US)$ to you guys since they sell heart meds
I would recommend $Cardiol Therapeutics (CRDL.US)$ to you guys since they sell heart meds
2
$Cardiol Therapeutics (CRDL.US)$ Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of
$13.5 Million
Toronto, ON - January 16, 2026 - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has entered into an agreement with a sole underwriter and sole bookrunner pursuant to which ...
$13.5 Million
Toronto, ON - January 16, 2026 - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has entered into an agreement with a sole underwriter and sole bookrunner pursuant to which ...
1
3
$Cardiol Therapeutics (CRDL.US)$ ok halt for news that meant nothing???
$Cardiol Therapeutics (CRDL.US)$ Trading Halt: Halted at 8:11:25 A.m. ET - Trading Halt: Halt News Pending
3
4
$Cardiol Therapeutics (CRDL.US)$ people jump on this !!!!!
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)